Gene therapy scores against cancer

被引：33

作者：

Anderson, WF ^{[1
]}

机构：

[1] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA

来源：

NATURE MEDICINE | 2000年 / 6卷 / 08期

关键词：

D O I：

10.1038/78610

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The first Phase II clinical trial to study the combination of a replicating viral agent with chemotherapy indicates that cancer gene therapy may finally be on the road to success. (879-885).

引用

页码：862 / 863

页数：2

共 9 条

[1] ADENOVIRUS PROTEINS FROM BOTH E1B READING FRAMES ARE REQUIRED FOR TRANSFORMATION OF RODENT CELLS BY VIRAL-INFECTION AND DNA TRANSFECTION
BARKER, DD
BERK, AJ
[J]. VIROLOGY, 1987, 156 (01) : 107 - 121
[2] T-LYMPHOCYTE-DIRECTED GENE-THERAPY FOR ADA(-) SCID - INITIAL TRIAL RESULTS AFTER 4 YEARS
BLAESE, RM
CULVER, KW
MILLER, AD
CARTER, CS
FLEISHER, T
CLERICI, M
SHEARER, G
CHANG, L
CHIANG, YW
TOLSTOSHEV, P
GREENBLATT, JJ
ROSENBERG, SA
KLEIN, H
BERGER, M
MULLEN, CA
RAMSEY, WJ
MUUL, L
MORGAN, RA
ANDERSON, WF
[J]. SCIENCE, 1995, 270 (5235) : 475 - 480
[3] Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
Cavazzana-Calvo, M
Hacein-Bey, S
Basile, CD
Gross, F
Yvon, E
Nusbaum, P
Selz, F
Hue, C
Certain, S
Casanova, JL
Bousso, P
Le Deist, F
Fischer, A
[J]. SCIENCE, 2000, 288 (5466) : 669 - 672
[4] ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
Heise, C
SampsonJohannes, A
Williams, A
McCormick, F
VonHoff, DD
Kirn, DH
[J]. NATURE MEDICINE, 1997, 3 (06) : 639 - 645
[5] Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
Isner, JM
Asahara, T
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) : 1231 - 1236
[6] Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
Kay, MA
Manno, CS
Ragni, MV
Larson, PJ
Couto, LB
McClelland, A
Glader, B
Chew, AJ
Tai, SJ
Herzog, RW
Arruda, V
Johnson, F
Scallan, C
Skarsgard, E
Flake, AW
High, KA
[J]. NATURE GENETICS, 2000, 24 (03) : 257 - 261
[7] A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
Khuri, FR
Nemunaitis, J
Ganly, I
Arseneau, J
Tannock, IF
Romel, L
Gore, M
Ironside, J
MacDougall, RH
Heise, C
Randlev, B
Gillenwater, AM
Bruso, P
Kaye, SB
Hong, WK
Kirn, DH
[J]. NATURE MEDICINE, 2000, 6 (08) : 879 - 885
[8] GENE-TRANSFER INTO HUMANS - IMMUNOTHERAPY OF PATIENTS WITH ADVANCED MELANOMA, USING TUMOR-INFILTRATING LYMPHOCYTES MODIFIED BY RETROVIRAL GENE TRANSDUCTION
ROSENBERG, SA
AEBERSOLD, P
CORNETTA, K
KASID, A
MORGAN, RA
MOEN, R
KARSON, EM
LOTZE, MT
YANG, JC
TOPALIAN, SL
MERINO, MJ
CULVER, K
MILLER, AD
BLAESE, RM
ANDERSON, WF
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (09) : 570 - 578
[9] INHIBITION OF P53 TRANSACTIVATION REQUIRED FOR TRANSFORMATION BY ADENOVIRUS EARLY 1B-PROTEIN
YEW, PR
BERK, AJ
[J]. NATURE, 1992, 357 (6373) : 82 - 85

← 1 →